Biden: U.S. exploring monkeypox vaccines; ?everybody? should be concerned
Companies, agencies, institutions, etc
the World Health Organization
WHO
the U.S. Centers for Disease Control and Prevention
the Johns Hopkins Center for Health Security
The Washington Post
CDC
Bavarian Nordic
JYNNEOS®
the U.S. Biomedical Advanced Research and Development Authority
Health and Human Services
Axios
IMVANEX®
British Health
Monkeypox.”UKHSA
Imvanex
El Pais
People
Biden
Jake Sullivan
Tom Inglesby
Imvanex
Jynneos
Sajid Javid
Kim
Meryl Kornfield
Hannah Knowles
Timothy Bella
Lindsey Bever
Groups
European
Spanish
Physical locations
Europe
Places
Tecovirimat
Locations
the United States
South Korea
Canada
Australia
Israel
Switzerland
U.S.
Massachusetts
New York City
Copenhagen
the United Kingdom
UK
Spain
Tokyo
Events
No matching tags
Summary
Under its agreement with the company, the U.S. Biomedical Advanced Research and Development Authority can still exercise options worth $180 million for about 13 million freeze-dried doses of the smallpox vaccine in the future.A Health and Human Services spokesperson told Axios that the purchase was not a direct response to the infections but said the doses could be used to treat monkeypox.Separately, Bavarian Nordic said it had “secured a contract with an undisclosed European country to supply its IMVANEX® smallpox vaccine in response to new cases of monkeypox evolving during May 2022.” Imvanex, as the Jynneos vaccine is known in Europe, is only licensed there for the treatment of smallpox, but it has been used “off-label” in previous monkeypox incidents.At least two European countries have moved to stockpile vaccines in a possible effort to get ahead of the spread.
As said here by Annabelle Timsit, Seung Min Kim